Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0R1MB
|
||||
| Former ID |
DNC013741
|
||||
| Drug Name |
DIHYDROAKUAMMINE
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [551355] | ||
| Formula |
C22H28N2O4
|
||||
| Canonical SMILES |
CC=C1CN2CCC34C2(CCC1C3(CO)C(=O)OC)N(C5=C4C=C(C=C5)O)C
|
||||
| InChI |
1S/C22H28N2O4/c1-4-14-12-24-10-9-21-17-11-15(26)5-6-18(17)23(2)22(21,24)8-7-16(14)20(21,13-25)19(27)28-3/h4-6,11,16,25-26H,7-10,12-13H2,1-3H3/b14-4-/t16-,20+,21+,22+/m1/s1
|
||||
| InChIKey |
SJFXTBHAODZALL-PEZZAXBTSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [551355] | |
| NetPath Pathway | TCR Signaling Pathway | ||||
| Pathway Interaction Database | IL4-mediated signaling events | ||||
| References | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.

